...Vivus granted Mist’s Metuchen Pharmaceuticals LLC affiliate exclusive rights to commercialize erectile dysfunction drug Stendra avanafil...
...Vivus has rights from the pharma outside Japan, China and certain other Pacific Rim countries. Stendra...

...The European Commission approved a label expansion for Spedra avanafil for erectile dysfunction (ED) to indicate...
...activity, down from about 30 minutes before sexual activity. Avanafil is approved in U.S. as Stendra...
...Corp. (Tokyo:4508), Osaka, Japan Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Product: Stendra avanafil ( Spedra , Zepeed...

...a long-acting implantable testosterone replacement therapy; and erectile dysfunction drugs Edex alprostadil and Stendra avanafil...
...E1, and Stendra is a fast-acting phosphodiesterase-5 (PDE-5) inhibitor. Auxilium has exclusive commercialization rights to Stendra...

...said FDA approved an sNDA to amend the label of erectile dysfunction (ED) drug Stendra avanafil...
...to close next quarter (see BioCentury, June 30). Avanafil is also approved in Europe as Spedra...
...Corp. (Tokyo:4508), Osaka, Japan Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Product: Stendra avanafil ( Spedra , Zepeed...

...after FDA approved an sNDA to amend the label of erectile dysfunction (ED) drug Stendra avanafil...
...now recommends the drug be taken about 15 minutes before sexual activity; it previously indicated Stendra...

...telmisartan and Micardis HCT telmisartan/hydrochlorothiazide (A) Boehringer Ingelheim GmbH ü Erectile dysfunction oral agents Stendra avanafil...

...NDA and MAA 4Q14 Vivus Inc. (NASDAQ:VVUS)/Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL)/Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) Stendra avanafil...

...approved products, including Xiaflex collagenase clostridium histolyticum for Peyronie’s disease and Dupuytren’s contracture and Stendra avanafil...

...approved products, including Xiaflex collagenase clostridium histolyticum for Peyronie's disease and Dupuytren's contracture and Stendra avanafil...

...In its 1Q14 earnings, Vivus disclosed that Menarini launched Spedra avanafil for erectile dysfunction in France...
...to disclose financial terms, including pricing information for the countries (see BioCentury, July 22, 2013). Spedra...